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Background: The elevation of cardiac biomarkers after percutaneous or surgical myocardial revascularization procedures is common. However, 
the correlation between the release and the diagnosis of procedure-related myocardial infarction (MI) remains unknown. In this study we aim to 
compare the release of cardiac biomarkers after mechanical interventions with the presence of late gadolinium enhancement (LGE) in cardiac 
magnetic resonance (CMR). 
methods: In this prospective study, we evaluated 64 stable multivessel coronary artery disease patients with preserved ventricular function and 
formal indication to revascularization. The release of troponin and CKMB for diagnosis of procedure-related MI was defined as the third universal 
definition of MI. CMR with LGE was performed in all patients before and after interventions. Measurements of cardiac biomarkers were performed 
before and after the procedure, every 6 hours until 48h after PCI and 72h after CABG. 
results: Of 64 patients, 44 (68.8%) underwent CABG and 20 (31.2%) underwent PCI; 46 (72%) were male, 45 (70%) had 3-vessel disease, 33 (52%) 
had diabetes and 23 (36%) had class III/IV of angina. For CABG patients, injury occurred in 95.5% (troponin) and 25% (CKMB); for PCI patients injury 
occurred in 70% (troponin) and 5% (CKMB). From the initial 64 patients, 14 (21.9%) had new LGE on post-procedure CMR, 13 after CABG and 1 after 
PCI. From these 14 patients, 7 (50%) presented elevation of CKMB above the cutoffs and troponin was elevated in all patients. From the 50 patients 
with no new LGE on CMR, 5 (10%) presented CKMB elevation and 42 (84%) presented troponin elevation above the 99th percentile. Based on current 
cutoffs, troponin had a sensitivity of 100% and specificity of 16% (positive predictive value of 25% and negative predictive value of 100%). CKMB had a 
sensitivity of 50% and specificity of 90% (positive predictive value of 58% and negative predictive value of 87%). 
conclusion: In this study, cardiac biomarkers had a low accuracy for the diagnosis of procedure-related myocardial infarction based on LGE CMR.
